Changes of Colonic Bacterial Composition in Parkinson’s Disease and Other Neurodegenerative Diseases

In recent years evidence has emerged that neurodegenerative diseases (NDs) are strongly associated with the microbiome composition in the gut. Parkinson’s disease (PD) is the most intensively studied neurodegenerative disease in this context. In this review, we performed a systematic evalu...

Full description

Bibliographic Details
Main Authors: Sara Gerhardt, M. Hasan Mohajeri
Format: Article
Language:English
Published: MDPI AG 2018-06-01
Series:Nutrients
Subjects:
Online Access:http://www.mdpi.com/2072-6643/10/6/708
id doaj-84f025a3cd2045f4a2856d9702d1128f
record_format Article
spelling doaj-84f025a3cd2045f4a2856d9702d1128f2020-11-25T00:57:19ZengMDPI AGNutrients2072-66432018-06-0110670810.3390/nu10060708nu10060708Changes of Colonic Bacterial Composition in Parkinson’s Disease and Other Neurodegenerative DiseasesSara Gerhardt0M. Hasan Mohajeri1Departement of human medicine, University of Zurich, Winterthurerstrasse 190, 8057 Zürich, SwitzerlandDepartement of human medicine, University of Zurich, Winterthurerstrasse 190, 8057 Zürich, SwitzerlandIn recent years evidence has emerged that neurodegenerative diseases (NDs) are strongly associated with the microbiome composition in the gut. Parkinson’s disease (PD) is the most intensively studied neurodegenerative disease in this context. In this review, we performed a systematic evaluation of the published literature comparing changes in colonic microbiome in PD to the ones observed in other NDs including Alzheimer’s disease (AD), multiple system atrophy (MSA), multiple sclerosis (MS), neuromyelitis optica (NMO) and amyotrophic lateral sclerosis (ALS). To enhance the comparability of different studies, only human case-control studies were included. Several studies showed an increase of Lactobacillus, Bifidobacterium, Verrucomicrobiaceae and Akkermansia in PD. A decrease of Faecalibacterium spp., Coprococcus spp., Blautia spp., Prevotella spp. and Prevotellaceae was observed in PD. On a low taxonomic resolution, like the phylum level, the changes are not disease-specific and are inconsistent. However, on a higher taxonomic resolution like genus or species level, a minor overlap was observed between PD and MSA, both alpha synucleinopathies. We show that standardization of sample collection and analysis is necessary for ensuring the reproducibility and comparability of data. We also provide evidence that assessing the microbiota composition at high taxonomic resolution reveals changes in relative abundance that may be specific to or characteristic of one disease or disease group, and might evolve discriminative power. The interactions between bacterial species and strains and the co-abundances must be investigated before assumptions about the effects of specific bacteria on the host can be made with certainty.http://www.mdpi.com/2072-6643/10/6/708Parkinson’s diseasegut microbiomeneurodegenerative diseasesmicrobiota–gut–brain axis
collection DOAJ
language English
format Article
sources DOAJ
author Sara Gerhardt
M. Hasan Mohajeri
spellingShingle Sara Gerhardt
M. Hasan Mohajeri
Changes of Colonic Bacterial Composition in Parkinson’s Disease and Other Neurodegenerative Diseases
Nutrients
Parkinson’s disease
gut microbiome
neurodegenerative diseases
microbiota–gut–brain axis
author_facet Sara Gerhardt
M. Hasan Mohajeri
author_sort Sara Gerhardt
title Changes of Colonic Bacterial Composition in Parkinson’s Disease and Other Neurodegenerative Diseases
title_short Changes of Colonic Bacterial Composition in Parkinson’s Disease and Other Neurodegenerative Diseases
title_full Changes of Colonic Bacterial Composition in Parkinson’s Disease and Other Neurodegenerative Diseases
title_fullStr Changes of Colonic Bacterial Composition in Parkinson’s Disease and Other Neurodegenerative Diseases
title_full_unstemmed Changes of Colonic Bacterial Composition in Parkinson’s Disease and Other Neurodegenerative Diseases
title_sort changes of colonic bacterial composition in parkinson’s disease and other neurodegenerative diseases
publisher MDPI AG
series Nutrients
issn 2072-6643
publishDate 2018-06-01
description In recent years evidence has emerged that neurodegenerative diseases (NDs) are strongly associated with the microbiome composition in the gut. Parkinson’s disease (PD) is the most intensively studied neurodegenerative disease in this context. In this review, we performed a systematic evaluation of the published literature comparing changes in colonic microbiome in PD to the ones observed in other NDs including Alzheimer’s disease (AD), multiple system atrophy (MSA), multiple sclerosis (MS), neuromyelitis optica (NMO) and amyotrophic lateral sclerosis (ALS). To enhance the comparability of different studies, only human case-control studies were included. Several studies showed an increase of Lactobacillus, Bifidobacterium, Verrucomicrobiaceae and Akkermansia in PD. A decrease of Faecalibacterium spp., Coprococcus spp., Blautia spp., Prevotella spp. and Prevotellaceae was observed in PD. On a low taxonomic resolution, like the phylum level, the changes are not disease-specific and are inconsistent. However, on a higher taxonomic resolution like genus or species level, a minor overlap was observed between PD and MSA, both alpha synucleinopathies. We show that standardization of sample collection and analysis is necessary for ensuring the reproducibility and comparability of data. We also provide evidence that assessing the microbiota composition at high taxonomic resolution reveals changes in relative abundance that may be specific to or characteristic of one disease or disease group, and might evolve discriminative power. The interactions between bacterial species and strains and the co-abundances must be investigated before assumptions about the effects of specific bacteria on the host can be made with certainty.
topic Parkinson’s disease
gut microbiome
neurodegenerative diseases
microbiota–gut–brain axis
url http://www.mdpi.com/2072-6643/10/6/708
work_keys_str_mv AT saragerhardt changesofcolonicbacterialcompositioninparkinsonsdiseaseandotherneurodegenerativediseases
AT mhasanmohajeri changesofcolonicbacterialcompositioninparkinsonsdiseaseandotherneurodegenerativediseases
_version_ 1725224682677862400